Press Releases

All Releases
Oct 13, 2014
AngioDynamics to be Added to the S&P SmallCap 600 Index
ALBANY, N.Y. , Oct. 13, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today it will be added to the S&P SmallCap 600 Index and the GICS Life
Oct 09, 2014
AngioDynamics Reports 2015 First Quarter Financial Results
First Quarter of Fiscal 2015 Net sales increased 4% to $87.3 million ; Sales grew 5%, excluding supply agreement Q1 FY15 GAAP $0.02 ; Non-GAAP adjusted net income of $0.16 per share Q1 FY15 EBITDA of $10.8 million , Adjusted EBITDA of $15.3 million Company provides second quarter guidance and
Sep 25, 2014
AngioDynamics to Report Fiscal 2015 First Quarter Financial Results
ALBANY, N.Y. , Sept. 25, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2015 first
Jun 11, 2014
AngioDynamics Awarded Premier Inc.'s Supplier Horizon Award
ALBANY, N.Y. , June 11, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today it is a winner of Premier Inc.'s first Supplier Horizon Award ,
May 28, 2014
AngioDynamics to Present at Jefferies Global Healthcare Conference
ALBANY, N.Y. , May 28, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today that Mark Frost , Executive Vice President and Chief Financial
May 06, 2014
AngioDynamics to Present at Upcoming Investor Conferences
ALBANY, N.Y. , May 6, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today the company will present at the following investor conferences in
Apr 09, 2014
AngioDynamics Reports Fiscal 2014 Third Quarter Financial Results
Net sales increase 8% over prior year to $88.2 million GAAP income per share of $0.14 ; Non-GAAP adjusted net income, excluding amortization, of $0.16 per share Adjusted EBITDA of $14.6 million Company's revenue guidance to $351 million - $355 million for FY14; Adjusted EPS, excluding amortization,
Mar 25, 2014
AngioDynamics to Report Fiscal 2014 Third Quarter Financial Results
ALBANY, N.Y. , March 25, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report its fiscal 2014 third quarter financial results
Mar 20, 2014
AngioDynamics Awarded $74.9 Million in Case Against biolitec AG
ALBANY, N.Y. , March 20, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced a recent court action in its legal case against biolitec AG.
Mar 11, 2014
AngioDynamics Receives Expanded FDA Clearance for AngioVac
ALBANY, N.Y. , March 11, 2014 (GLOBE NEWSWIRE) -- AngioDynamics (Nasdaq:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced the U.S. Food and Drug Administration (FDA) cleared an expanded
Displaying 101 - 120 of 629